Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board
Read more here


Intezyne Technologies Expands Executive Leadership Team with Two Key Appointments
Read more here


Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million in Connection with Going Public Transaction
Read more here